Case Comprehensive Cancer Center
August 16, 2024
January 2022 debuted Reshmi Parameswaran's novel B-cell activating factor (BAFF) CAR T product effective at killing multiple B-cell cancers with robust in vitro and in vivo cytotoxicity exerted by these cells against mantle cell lymphoma, multiple myeloma, and acute lymphoblastic leukemia. This…
August 16, 2024
If you haven't met Faye Gary, EdD, RN, FAAN, you should. A tiny bundle of energy, she exudes compassion while commanding a room of high schoolers or an auditorium of her peers. She rarely takes "no" for an answer, and she gets things done. Gary, a CWRU Distinguished University Professor, is one of…
August 09, 2024
Case CCC Molecular Oncology Program member Khalid Sossey-Alaoui, PhD, and Thomas Jefferson University's Lucia Languino, PhD, conducted a collaborative study that appears in a recent Journal of Extracellular Vesicles. The study, Expression of the αVβ3 integrin affects prostate cancer sEV cargo and…
August 09, 2024
Daniel Spratt, MD, member of Case CCC's Developmental Therapeutics Program, conducted a retrospective cohort study assessing the associations between the Decipher Genomic Classifier (Decipher GC), a test that improves understanding of the aggressiveness of a patient's prostate cancer, and risks of…

August 05, 2024
Case Comprehensive Cancer Center (Case CCC) and Cleveland Metroparks have partnered to make it easier for people to prevent skin cancer. Free sunscreen will be available to all visitors at participating Cleveland Metroparks beaches and golf courses. The project, “Be Sun Smart. Protect Your Skin…
August 02, 2024
Case CCC Population and Cancer Prevention Program member, Mohamed Draz, PhD, provided background information for a study published this week in MDLinx that indicates honey bees can detect certain cancers with nearly 90% accuracy. Draz explains, “Cancer metabolism produces specific compounds that…
August 02, 2024
Schmit Study Determining CRC Screening Priority Areas Published in American Journal of Public Health
A study with Case CCC's Population and Cancer Prevention Co-Leader Stephanie Schmit, PhD, MPH, as Principal Investigator aims to close the healthcare gap that disproportionately affects Hispanic/Latino (H/L) communities in the U.S. by identifying colorectal cancer screening (CRC) screening…
July 29, 2024
Case Comprehensive Cancer Center (Case CCC) and Cleveland Metroparks have partnered to make it easier for people to prevent skin cancer. Free sunscreen will be available to all visitors at participating Cleveland Metroparks beaches and golf courses. The project, "Be Sun Smart. Protect Your Skin…

July 16, 2024
The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge. Despite the expectation that resistance-conferring mutations would dwindle in the absence of treatment due to a reduced growth rate, preexisting resistance is pervasive across diseases…

July 12, 2024
Reda Riffi, a first-generation student at Case Western Reserve University, was selected to participate in the BioMed Amgen Scholars Program at Yale University this summer. Riffi is majoring in neuroscience and conducts research at CWRU in the Xiong Lab. The BioMed Amgen Scholars Program is a…